Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 298 (RNA5SP298)

Target
RNA5SP298
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA (pseudogene subclass)
01

Overview

RNA, 5S ribosomal pseudogene 298 (RNA5SP298) is categorized as a processed pseudogene derived from the 5S ribosomal RNA gene family, and is found in the human genome. Pseudogenes like RNA5SP298 are typically non-functional DNA sequences that resemble functional genes but contain mutations or rearrangements preventing normal expression or function[1][2][4]. While the functional 5S ribosomal RNA is a structural component of the ribosome and critical for protein synthesis[5][3], pseudogenes such as RNA5SP298 likely arose through duplication and retrotransposition events in genomic evolution[4]. They do not encode functional RNA or protein, nor do they exhibit direct cellular roles, although global pseudogene expression patterns may have regulatory or biomarker potential in the context of cancer[6]. No known therapeutic agents, clinical biomarkers, or disease mechanisms have been attributed to this specific pseudogene. Its scientific interest is restricted to evolutionary genomics and potential non-coding RNA transcriptome analyses.

Other names
RN5S298RNA5SP298RNA, 5S ribosomal 298
02

Mechanism of action

Not applicable; no drugs target this pseudogene.

03

Biological functions

Other (no experimentally defined function; annotated as a processed pseudogene)Genomic region related to ribosomal RNA gene evolutionPotential regulatory RNA (in general, some pseudogenes can act in regulatory networks, but RNA5SP298 has no specific function reported)
04

Disease associations

Other. No direct evidence linking RNA5SP298 as a driver or marker for disease. However, recent research demonstrates that some pseudogenes may be dysregulated in cancer or act as biomarkers or modulators of disease pathways when expressed. No evidence is specific for RNA5SP298.
05

Safety considerations

None directly associated, since RNA5SP298 is not a direct therapeutic target or biomarker with actionable use.
06

Biomarkers

None known for patient selection or efficacy monitoring. However, large-scale studies suggest the possible utility of pseudogene expression profiles (not specifically RNA5SP298) as cancer biomarkers.

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 298 (RNA5SP298).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 298 (RNA5SP298).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call